On December 7, 2012, Utah Medical Products, Inc. (UTMD) and JPMorgan Chase Bank, N.A. (Chase) modified the loan agreement they entered into on March 17, 2011 and subsequently amended on September 23, 2011. This second amendment reduces the monthly principal payment to $116,666.67 from $233,333.33. The 50% reduction is needed because UTMD has paid off $9.3 million of the $14.0 million initial loan amount in the first 20 months of the 5 year loan. A copy of the modification agreement is attached hereto as Exhibit 1.

The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

(d) Exhibits

              SEC
Exhibit # Reference # Title of Document
   111
    1         10      Second Modification Agreement dated as of December 7, 2012 among
                      Utah Medical Products, Inc., as Borrower, and JPMorgan Chase Bank,
                      N.A., as Lender